FCB Health Network president & CEO Dana Maiman announced Jill Lesiak joined Mosaic Group – the Network’s full-service payer and market access healthcare agency – as executive creative director.
Huntsworth, an international healthcare and communications group, announced an agreement to acquire Nucleus Global, one of the world’s largest medical specialist communications groups.
EVERSANA™ expands pharmaceutical training and digital engagement capabilities with acquisition of Alkemy Partners CHICAGO, Sept. 9, 2020 /PRNewswire/ — EVERSANA™, the leading provider of commercial services to the life science industry, today announced the acquisition of Alkemy Partners, a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, […]
EVERSAN and Havas Health & You announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and wellness clients worldwide.
Global healthcare communications agency Fishawack Health acquired Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the United States.
EVERSANA launched full-solution healthcare marketing agency EVERSANA ENGAGE, which is uniquely designed to help pharma and biotech companies cohesively reach patients, payers and providers to enhance the patient experience and improve outcomes.
As part of Fingerpaint’s continued commitment to bring forward the best opportunities to their clients, the full-service health and wellness marketing agency acquired 1798, a market access and commercialization firm located in La Jolla, Calif.
EVERSANA unveiled EVERSANA ENGAGE, a full-solution healthcare marketing agency uniquely designed to help pharma and biotech companies cohesively reach patients, providers and payers to enhance patient experience and improve outcomes.
The Sumitomo Dainippon-Roivant Alliance encompasses up to 11 biopharmaceutical Vants with more than 25 innovative clinical programs and multiple potential product launches from 2020 to 2022, and access to key elements of Roivant’s proprietary technology platforms including DrugOme and Digital Innovation.
The marketplace is changing. It has become cliché to say it. In fact, for years the healthcare market access space has been under pressure to evolve, grow, and reinvent itself – all while digging in its heels and clinging to a vanishing status quo.